Skip Nav Destination
Issues
1 December 2007
-
Cover Image
Cover Image
Zebrafish are a popular model organism for studying embryonic vascular development. Recent studies have shown that clinical stage anti-angiogenic compounds can inhibit vascular growth in zebrafish. In this issue, Tran and colleagues sought to use zebrafish as a tool to discover new anti-angiogenic compounds. Transgenic zebrafish expressing a green fluorescent reporter protein specifically in the vasculature were employed to develop an automated, quantitative screening assay for anti-angiogenic compound activity. The methods developed include automated determination of angiogenic blood vessel count in the trunk of zebrafish embryos. The assay was used to screen a 1280 compound library. Two known anti-angiogenic compounds were identified in the screen. Additionally, a novel anti-angiogenic compound, indirubin-3’-monoxime, was discovered. These results show that zebrafish can be used as a drug discovery tool to identify newanti-angiogenic compounds. For details, see the article by Tran and colleagues on page 11386 of this issue.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Reviews
Meeting Report
Priority Reports
Cells Deficient in the FANC/BRCA Pathway Are Hypersensitive to Plasma Levels of Formaldehyde
John R. Ridpath; Ayumi Nakamura; Keizo Tano; April M. Luke; Eiichiro Sonoda; Hiroshi Arakawa; Jean-Marie Buerstedde; David A.F. Gillespie; Julian E. Sale; Mitsuyoshi Yamazoe; Douglas K. Bishop; Minoru Takata; Shunichi Takeda; Masami Watanabe; James A. Swenberg; Jun Nakamura
Variants on 9p24 and 8q24 Are Associated with Risk of Colorectal Cancer: Results from the Colon Cancer Family Registry
Jenny N. Poynter; Jane C. Figueiredo; David V. Conti; Kathleen Kennedy; Steven Gallinger; Kimberly D. Siegmund; Graham Casey; Stephen N. Thibodeau; Mark A. Jenkins; John L. Hopper; Graham B. Byrnes; John A. Baron; Ellen L. Goode; Maarit Tiirikainen; Noralane Lindor; John Grove; Polly Newcomb; Jeremy Jass; Joanne Young; John D. Potter; Robert W. Haile; David J. Duggan; Loic Le Marchand; for the Colon CFR
Molecular Biology, Pathobiology, and Genetics
Direct Transcriptional Activation of Promyelocytic Leukemia Protein by IFN Regulatory Factor 3 Induces the p53-Dependent Growth Inhibition of Cancer Cells
Tae-Kyung Kim; Joong-Seob Lee; Se-Yeong Oh; Xun Jin; Yun-Jaie Choi; Tae-Hoon Lee; Eun ho Lee; Young-Ki Choi; Seungkwon You; Yong Gu Chung; Jang-Bo Lee; Ronald A. DePinho; Lynda Chin; Hyunggee Kim
CD83 Gene Polymorphisms Increase Susceptibility to Human Invasive Cervical Cancer
Zhengyan Zhang; Ingrid Borecki; Loan Nguyen; Duanduan Ma; Kimberly Smith; Phyllis C. Huettner; David G. Mutch; Thomas J. Herzog; Randall K. Gibb; Matthew A. Powell; Perry W. Grigsby; L. Stewart Massad; Enrique Hernandez; Patricia L. Judson; Elizabeth M. Swisher; Sara Crowder; Jianduan Li; Daniela S. Gerhard; Janet S. Rader
Cell, Tumor, and Stem Cell Biology
Neuroblastoma Cells Isolated from Bone Marrow Metastases Contain a Naturally Enriched Tumor-Initiating Cell
Loen M. Hansford; Amy E. McKee; Libo Zhang; Rani E. George; J. Ted Gerstle; Paul S. Thorner; Kristen M. Smith; A. Thomas Look; Herman Yeger; Freda D. Miller; Meredith S. Irwin; Carol J. Thiele; David R. Kaplan
Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo
Ji-Liang Li; Richard C.A. Sainson; Wen Shi; Russell Leek; Laura S. Harrington; Matthias Preusser; Swethajit Biswas; Helen Turley; Emily Heikamp; Johannes A. Hainfellner; Adrian L. Harris
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Genetic Alterations in the Tyrosine Kinase Transcriptome of Human Cancer Cell Lines
Jens E. Ruhe; Sylvia Streit; Stefan Hart; Chee-Hong Wong; Katja Specht; Pjotr Knyazev; Tatjana Knyazeva; Liang Seah Tay; Hooi Linn Loo; Priscilla Foo; Winnie Wong; Sharon Pok; Shu Jing Lim; Huimin Ong; Ming Luo; Han Kiat Ho; Kaitian Peng; Tze Chuen Lee; Martin Bezler; Christian Mann; Silvia Gaertner; Heinz Hoefler; Stefano Iacobelli; Stephan Peter; Alice Tay; Sydney Brenner; Byrappa Venkatesh; Axel Ullrich
Immunology
Epidemiology
Prevention
3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition
David B. Solit; Elmer Santos; Christine A. Pratilas; Jose Lobo; Maxim Moroz; Shangde Cai; Ronald Blasberg; Judith Sebolt-Leopold; Steven Larson; Neal Rosen
Correction
Advertisement